Significant Ownership of Innoviva, Inc.

Signature - Title
/s/ Pavel Raifeld - Pavel Raifeld, Chief Executive Officer
Location
Burlingame, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Innoviva, Inc..

Notify me when Innoviva, Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Innoviva, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMP Armata Pharmaceuticals, Inc. Common Stock, $0.01 par value 83% $75,990,419 -$11,933,796 55,467,459 -14% Innoviva, Inc. 11 Aug 2025

Schedules 13D/G Reported by Innoviva, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.